Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 72229-07-3 | MDL No. : | MFCD22495173 |
Formula : | C8H12O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UWYCEOHZDOYNHX-UHFFFAOYSA-N |
M.W : | 172.18 g/mol | Pubchem ID : | 274392 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.75 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 41.03 |
TPSA : | 52.6 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.97 cm/s |
Log Po/w (iLOGP) : | 2.27 |
Log Po/w (XLOGP3) : | 0.54 |
Log Po/w (WLOGP) : | 0.5 |
Log Po/w (MLOGP) : | 0.54 |
Log Po/w (SILICOS-IT) : | 0.8 |
Consensus Log Po/w : | 0.93 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.92 |
Solubility : | 20.8 mg/ml ; 0.121 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.22 |
Solubility : | 10.5 mg/ml ; 0.0608 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.8 |
Solubility : | 27.2 mg/ml ; 0.158 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.89 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86 % de | With Cu exchanged bentonite In neat (no solvent) at 80℃; for 0.333333 h; Microwave irradiation | General procedure: Method A (MWI): in this study a continuous focusedmicrowave (synthewave 402 apparatus with a max power of300 W) with refluxing and stirring option was used. Thereaction temperature was reached a target temperature after3min then maintained by device until the end of reaction.The temperature was detected by IR sensor.The mixture of the alkene (6 mmol) and the exchangedbentonite 50 mg was irradiated at 150 Watts to reach 80°C,in a quartz reactor ( = 1.8 cm). The temperature was maintainedfor 20 minutes and during that time, EDA (6 mmol) inalkene (6mmol) was added slowly by a syringe during 10min. When the reaction was complete, the crud mixture wasobtained after adding dichloromethane (3x20mL), filtrationand removal of the excess of alkene and solvent. The crudewas analyzed by 1H NMR and then the product is purified byshort-path distillation. The obtained cyclopropane is identifiedby 1H NMR, 13C NMR and mass spectra. |
[ 78932-45-3 ]
Ethyl 2-butoxycyclopropanecarboxylate
Similarity: 1.00
[ 168141-89-7 ]
rel-(1R,2S)-Methyl 2-acetoxycyclopropanecarboxylate
Similarity: 1.00
[ 492468-17-4 ]
(1R,2S)-Ethyl 2-ethoxycyclopropanecarboxylate
Similarity: 1.00
[ 168141-88-6 ]
rel-(1R,2R)-Methyl 2-acetoxycyclopropanecarboxylate
Similarity: 1.00
[ 78932-45-3 ]
Ethyl 2-butoxycyclopropanecarboxylate
Similarity: 1.00